189 related articles for article (PubMed ID: 11881601)
1. FDA approves Viread for HIV-1 infection.
FDA Consum; 2002; 36(1):5. PubMed ID: 11881601
[No Abstract] [Full Text] [Related]
2. Viread gets FDA nod.
Rodriquez E
Posit Living; 2001 Dec-2002 Jan; 10(7):33. PubMed ID: 11808509
[No Abstract] [Full Text] [Related]
3. Tenofovir: FDA hearing October 3, public comment deadlines September 26.
James JS
AIDS Treat News; 2001 Aug; (370):3-4. PubMed ID: 11570163
[No Abstract] [Full Text] [Related]
4. Gilead sciences releases Viread.
Giles C
Surviv News (Atlanta Ga); 2002 Jan; ():15. PubMed ID: 11870987
[No Abstract] [Full Text] [Related]
5. FDA grants tentative approval to first generic version of antiretroviral Viread.
AIDS Patient Care STDS; 2008 Jan; 22(1):86. PubMed ID: 18453039
[No Abstract] [Full Text] [Related]
6. Tenofovir: FDA hearing on important new antiretroviral.
James JS
AIDS Treat News; 2001 Oct; (372):2-4. PubMed ID: 11702411
[No Abstract] [Full Text] [Related]
7. Generic Truvada approved.
AIDS Patient Care STDS; 2009 May; 23(5):395. PubMed ID: 19422066
[No Abstract] [Full Text] [Related]
8. FDA approves tenofovir.
AIDS Patient Care STDS; 2002 Jan; 16(1):52. PubMed ID: 11892608
[No Abstract] [Full Text] [Related]
9. Tenofovir (viread) receives FDA approval.
AIDS Alert; 2002 Jan; 17(1):10-1. PubMed ID: 11862732
[No Abstract] [Full Text] [Related]
10. Tenofovir: Gilead applies for approval; expanded access liberalized.
Gilden D
AIDS Treat News; 2001 May; (364):2-3, 1. PubMed ID: 11569959
[TBL] [Abstract][Full Text] [Related]
11. Tenofovir approved: broad indication.
James JS
AIDS Treat News; 2001 Oct; (373):2-3. PubMed ID: 11768879
[No Abstract] [Full Text] [Related]
12. [First nucleotide analog on the market. New drug for the pretreated patient].
MMW Fortschr Med; 2002 Apr; 144 Suppl 1():84. PubMed ID: 12043094
[No Abstract] [Full Text] [Related]
13. New antiretroviral for HIV infection.
Am Fam Physician; 2002 Mar; 65(5):987. PubMed ID: 11898969
[No Abstract] [Full Text] [Related]
14. BMS issues PK notice regarding ATV + TDF.
IAPAC Mon; 2003 Sep; 9(9):203. PubMed ID: 14672069
[No Abstract] [Full Text] [Related]
15. Expanded access.
Proj Inf Perspect; 1999 Sep; (28):8. PubMed ID: 11367366
[TBL] [Abstract][Full Text] [Related]
16. [Tenofovir--a new option for combination therapy].
Polk B
Med Monatsschr Pharm; 2002 Apr; 25(4):140-1. PubMed ID: 12017127
[No Abstract] [Full Text] [Related]
17. [Further indications for tenofovir].
Dtsch Med Wochenschr; 2003 Sep; 128(39):2037. PubMed ID: 14565207
[No Abstract] [Full Text] [Related]
18. Tenofovir DF expanded access. Criteria for U.S. program.
AIDS Treat News; 2001 Feb; (360):2-3. PubMed ID: 12173565
[TBL] [Abstract][Full Text] [Related]
19. [Tenofovir (Viread)].
Sidahora; 2002; (1):20-1. PubMed ID: 12772661
[No Abstract] [Full Text] [Related]
20. [No comparison with NRTI. Tenofovir is robust against resistance trouble].
MMW Fortschr Med; 2002 Apr; 144 Suppl 1():65. PubMed ID: 12043079
[No Abstract] [Full Text] [Related]
[Next] [New Search]
